Search

Author/Creator Baker, Emma H.

2. A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID‐19 (SARS‐COV‐2) treatments. Issue 3 (19th June 2020)

Authors:
Baker, Emma H.; Gnjidic, Danijela; Kirkpatrick, Carl M.J.; Pirmohamed, Munir; Wright, Daniel F.B.; Zecharia, Anna Y.
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 3(2021)
Page Start:
707
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A case series of vaccine‐induced thrombotic thrombocytopenia in a London teaching hospital. Issue 4 (9th November 2021)

Authors:
Watts, Isabella; Smith, David; Mounter, Sarah; Baker, Emma H.; Hitchings, Andrew W.; Gill, Dipender
Other Names:
Bies Rob guestEditor.; Wright Dan guestEditor.
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 4(2022)
Page Start:
1935
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Development of a structured clinical pharmacology review for specialist support for management of complex polypharmacy in primary care. Issue 7 (16th March 2020)

Authors:
Threapleton, Christopher J.D.; Kimpton, James E.; Carey, Iain M.; DeWilde, Stephen; Cook, Derek G.; Harris, Tess; Baker, Emma H.
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 7(2020)
Page Start:
1326
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Growth differentiation factor‐15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. Issue 4 (29th December 2015)

Authors:
Patel, Mehul S.; Lee, Jen; Baz, Manuel; Wells, Claire E.; Bloch, Susannah; Lewis, Amy; Donaldson, Anna V.; Garfield, Benjamin E.; Hopkinson, Nicholas S.; Natanek, Amanda; Man, William D‐C; Wells, Dominic J.; Baker, Emma H.; Polkey, Michael I.; Kemp, Paul R.
Journal:
Journal of cachexia, sarcopenia and muscle
Issue:
Volume 7:Issue 4(2016)
Page Start:
436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Insights from compassionate use of tocilizumab for COVID‐19 to inform appropriate design of randomised controlled trials. Issue 3 (14th July 2020)

Authors:
Baker, Emma H.; Patel, Kamal; Ball, Jonathan; Edwards, Sarah; Harrison, Thomas S.; Kaul, Arvind; Koh, Mickey; Krishna, Sanjeev; Leaver, Susannah; Kumar, Vinodh; Forton, Daniel M.
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 3(2021)
Page Start:
1584
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre‐emptive pharmacogenomic testing. Issue 12 (13th December 2019)

Authors:
Kimpton, James E.; Carey, Iain M.; Threapleton, Christopher J.D.; Robinson, Alexandra; Harris, Tess; Cook, Derek G.; DeWilde, Stephen; Baker, Emma H.
Journal:
British journal of clinical pharmacology
Issue:
Volume 85:Issue 12(2019)
Page Start:
2734
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Metformin attenuates the effect of Staphylococcus aureus on airway tight junctions by increasing PKCζ‐mediated phosphorylation of occludin. Issue 1 (18th November 2018)

Authors:
Kalsi, Kameljit K.; Garnett, James P.; Patkee, Wishwanath; Weekes, Alexina; Dockrell, Mark E.; Baker, Emma H.; Baines, Deborah L.
Journal:
Journal of cellular and molecular medicine
Issue:
Volume 23:Issue 1(2019)
Page Start:
317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗